MedTrace Logo

Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases

NCT06459713 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2024-06-14

No results posted yet for this study

Summary

Multiplex respiratory polymerase chain reaction (PCR) test has gained wide acceptance as an alternative to conventional culture methods for the detection of the causative agent of community-acquired pneumonia (CAP). The aim of this study is to evaluate the positivity and to determine the causative agent of CAP using multiplex respiratory PCR test in patients with diabetes mellitus.

Conditions

  • Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases

Interventions

DIAGNOSTIC_TEST

multiplex respiratory polymerase chain reaction test

According to our hospital policy, nasopharyngeal swab samples are collected by the clinicians and transported to the Clinical Microbiology Laboratory of the hospital in 10 minutes. The samples are analyzed in 2 hours and the samples were measured by Thermo Fisher / Applied Biosystems Quant Studio-5 for reverse transcription-polymerase chain reaction (RT-PCR) testing to detect multiplex respiratory agents

Sponsors & Collaborators

  • Hisar Intercontinental Hospital

    lead OTHER

Principal Investigators

  • Yakup Tomak · Hisar Intercontinental Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-05-15
Completion
2024-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06459713 on ClinicalTrials.gov